BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 37666995)

  • 1. Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells.
    Bertolino GM; Maumus M; Jorgensen C; Noël D
    Nat Rev Rheumatol; 2023 Nov; 19(11):682-694. PubMed ID: 37666995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.
    Cosenza S; Ruiz M; Maumus M; Jorgensen C; Noël D
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases.
    Didamoony MA; Soubh AA; Atwa AM; Ahmed LA
    Inflammopharmacology; 2023 Dec; 31(6):2973-2993. PubMed ID: 37874430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stromal/stem Cell-derived Extracellular Vesicles Promote Human Cartilage Regeneration
    Vonk LA; van Dooremalen SFJ; Liv N; Klumperman J; Coffer PJ; Saris DBF; Lorenowicz MJ
    Theranostics; 2018; 8(4):906-920. PubMed ID: 29463990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency Assay Considerations for Cartilage Repair, Osteoarthritis and Use of Extracellular Vesicles.
    Vonk LA
    Adv Exp Med Biol; 2023; 1420():59-80. PubMed ID: 37258784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of extracellular vesicles derived from mesenchymal stem cells as potential therapeutic tools in autoimmune and rheumatic diseases.
    Huldani H; Abdalkareem Jasim S; Olegovich Bokov D; Abdelbasset WK; Nader Shalaby M; Thangavelu L; Margiana R; Qasim MT
    Int Immunopharmacol; 2022 May; 106():108634. PubMed ID: 35193053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeno-free cultured mesenchymal stromal cells release extracellular vesicles with a "therapeutic" miRNA cargo ameliorating cartilage inflammation
    Palamà MEF; Coco S; Shaw GM; Reverberi D; Ghelardoni M; Ostano P; Chiorino G; Sercia L; Persano L; Gagliani MC; Cortese K; Pisignano D; Murphy JM; Gentili C
    Theranostics; 2023; 13(5):1470-1489. PubMed ID: 37056573
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases.
    Yang JH; Liu FX; Wang JH; Cheng M; Wang SF; Xu DH
    World J Stem Cells; 2020 Jul; 12(7):688-705. PubMed ID: 32843922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.
    Zheng G; Huang R; Qiu G; Ge M; Wang J; Shu Q; Xu J
    Cell Tissue Res; 2018 Oct; 374(1):1-15. PubMed ID: 29955951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions.
    Ryan ST; Hosseini-Beheshti E; Afrose D; Ding X; Xia B; Grau GE; Little CB; McClements L; Li JJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
    Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
    Front Immunol; 2018; 9():2538. PubMed ID: 30473695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
    Ragni E; Perucca Orfei C; De Luca P; Mondadori C; Viganò M; Colombini A; de Girolamo L
    Stem Cell Res Ther; 2020 Apr; 11(1):165. PubMed ID: 32345351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles derived from LPS-preconditioned human synovial mesenchymal stem cells inhibit extracellular matrix degradation and prevent osteoarthritis of the knee in a mouse model.
    Duan A; Shen K; Li B; Li C; Zhou H; Kong R; Shao Y; Qin J; Yuan T; Ji J; Guo W; Wang X; Xue T; Li L; Huang X; Sun Y; Cai Z; Liu W; Liu F
    Stem Cell Res Ther; 2021 Jul; 12(1):427. PubMed ID: 34321073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management.
    Nguyen TH; Duong CM; Nguyen XH; Than UTT
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.
    Ossendorff R; Grad S; Tertel T; Wirtz DC; Giebel B; Börger V; Schildberg FA
    Front Immunol; 2023; 14():1198198. PubMed ID: 37564645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem/stromal cells-derived extracellular vesicles as a potentially more beneficial therapeutic strategy than MSC-based treatment in a mild metabolic osteoarthritis model.
    Warmink K; Rios JL; Varderidou-Minasian S; Torres-Torrillas M; van Valkengoed DR; Versteeg S; Eijkelkamp N; Weinans H; Korthagen NM; Lorenowicz MJ
    Stem Cell Res Ther; 2023 May; 14(1):137. PubMed ID: 37226203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritis.
    Boulestreau J; Maumus M; Jorgensen C; Noël D
    Adv Drug Deliv Rev; 2021 Aug; 175():113836. PubMed ID: 34166759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.
    Zhou H; Shen X; Yan C; Xiong W; Ma Z; Tan Z; Wang J; Li Y; Liu J; Duan A; Liu F
    Stem Cell Res Ther; 2022 Jul; 13(1):322. PubMed ID: 35842714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles: A new therapeutic strategy for joint conditions.
    Tofiño-Vian M; Guillén MI; Alcaraz MJ
    Biochem Pharmacol; 2018 Jul; 153():134-146. PubMed ID: 29427625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.
    Ophelders DR; Wolfs TG; Jellema RK; Zwanenburg A; Andriessen P; Delhaas T; Ludwig AK; Radtke S; Peters V; Janssen L; Giebel B; Kramer BW
    Stem Cells Transl Med; 2016 Jun; 5(6):754-63. PubMed ID: 27160705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.